Cargando…
P1091: FEASIBILITY OF ASCT AFTER ANTI-PD-1 THERAPY FOR R/R CLASSICAL HODGKIN LYMPHOMA
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9428970/ http://dx.doi.org/10.1097/01.HS9.0000847232.50505.64 |
| _version_ | 1784779286259957760 |
|---|---|
| author | Mochkin, N. Sarzhevskiy, V. Protopopova, Y. Demina, E. Melnichenko, V. Bogatyrev, V. Samoylova, A. Mamedova, A. Rukavitsyn, A. Bannikova, A. Smirnova, E. Shorokhov, N. |
| author_facet | Mochkin, N. Sarzhevskiy, V. Protopopova, Y. Demina, E. Melnichenko, V. Bogatyrev, V. Samoylova, A. Mamedova, A. Rukavitsyn, A. Bannikova, A. Smirnova, E. Shorokhov, N. |
| author_sort | Mochkin, N. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9428970 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94289702022-08-31 P1091: FEASIBILITY OF ASCT AFTER ANTI-PD-1 THERAPY FOR R/R CLASSICAL HODGKIN LYMPHOMA Mochkin, N. Sarzhevskiy, V. Protopopova, Y. Demina, E. Melnichenko, V. Bogatyrev, V. Samoylova, A. Mamedova, A. Rukavitsyn, A. Bannikova, A. Smirnova, E. Shorokhov, N. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9428970/ http://dx.doi.org/10.1097/01.HS9.0000847232.50505.64 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Mochkin, N. Sarzhevskiy, V. Protopopova, Y. Demina, E. Melnichenko, V. Bogatyrev, V. Samoylova, A. Mamedova, A. Rukavitsyn, A. Bannikova, A. Smirnova, E. Shorokhov, N. P1091: FEASIBILITY OF ASCT AFTER ANTI-PD-1 THERAPY FOR R/R CLASSICAL HODGKIN LYMPHOMA |
| title | P1091: FEASIBILITY OF ASCT AFTER ANTI-PD-1 THERAPY FOR R/R CLASSICAL HODGKIN LYMPHOMA |
| title_full | P1091: FEASIBILITY OF ASCT AFTER ANTI-PD-1 THERAPY FOR R/R CLASSICAL HODGKIN LYMPHOMA |
| title_fullStr | P1091: FEASIBILITY OF ASCT AFTER ANTI-PD-1 THERAPY FOR R/R CLASSICAL HODGKIN LYMPHOMA |
| title_full_unstemmed | P1091: FEASIBILITY OF ASCT AFTER ANTI-PD-1 THERAPY FOR R/R CLASSICAL HODGKIN LYMPHOMA |
| title_short | P1091: FEASIBILITY OF ASCT AFTER ANTI-PD-1 THERAPY FOR R/R CLASSICAL HODGKIN LYMPHOMA |
| title_sort | p1091: feasibility of asct after anti-pd-1 therapy for r/r classical hodgkin lymphoma |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9428970/ http://dx.doi.org/10.1097/01.HS9.0000847232.50505.64 |
| work_keys_str_mv | AT mochkinn p1091feasibilityofasctafterantipd1therapyforrrclassicalhodgkinlymphoma AT sarzhevskiyv p1091feasibilityofasctafterantipd1therapyforrrclassicalhodgkinlymphoma AT protopopovay p1091feasibilityofasctafterantipd1therapyforrrclassicalhodgkinlymphoma AT deminae p1091feasibilityofasctafterantipd1therapyforrrclassicalhodgkinlymphoma AT melnichenkov p1091feasibilityofasctafterantipd1therapyforrrclassicalhodgkinlymphoma AT bogatyrevv p1091feasibilityofasctafterantipd1therapyforrrclassicalhodgkinlymphoma AT samoylovaa p1091feasibilityofasctafterantipd1therapyforrrclassicalhodgkinlymphoma AT mamedovaa p1091feasibilityofasctafterantipd1therapyforrrclassicalhodgkinlymphoma AT rukavitsyna p1091feasibilityofasctafterantipd1therapyforrrclassicalhodgkinlymphoma AT bannikovaa p1091feasibilityofasctafterantipd1therapyforrrclassicalhodgkinlymphoma AT smirnovae p1091feasibilityofasctafterantipd1therapyforrrclassicalhodgkinlymphoma AT shorokhovn p1091feasibilityofasctafterantipd1therapyforrrclassicalhodgkinlymphoma |